R1507, an anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, and EWS/FLI-1 siRNA in Ewing's sarcoma: convergence at the IGF/IGFR/Akt axis.
A subset of patients with Ewing's sarcoma responds to anti-insulin-like growth factor-1 receptor (IGF-1R) antibodies. Mechanisms of sensitivity and resistance are unknown. We investigated whether an anti-IGF-1R antibody acts via a pathway that could also be suppressed by small interfering (si)...
Main Authors: | Helen J Huang, Laura S Angelo, Jordi Rodon, Michael Sun, Klaus-Peter Kuenkele, Henrique A Parsons, Jonathan C Trent, Razelle Kurzrock |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3191161?pdf=render |
Similar Items
-
High expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-IGF-1R antibody (R1507).
by: Yixuan Gong, et al.
Published: (2009-10-01) -
Targeted morphoproteomic profiling of Ewing's sarcoma treated with insulin-like growth factor 1 receptor (IGF1R) inhibitors: response/resistance signatures.
by: Vivek Subbiah, et al.
Published: (2011-04-01) -
IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers
by: Hesham M. Amin, et al.
Published: (2020-07-01) -
IR/IGFR hybrids : tools for studying insulin and IGF-1 binding and action
by: Benyoucef, Samira
Published: (2006) -
IGF1R signaling in Ewing sarcoma is shaped by clathrin-/caveolin-dependent endocytosis.
by: Ana Sofia Martins, et al.
Published: (2011-01-01)